Sung Lee
CFO at Cytokinetics Inc (CYTK)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $5.7M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 2SEC | CYTKCytokinetics Inc | Sell Plan | 1,11263,221 held (−2%) | $87.79 | $98K | -28.3% |
| Jun 29SEC | CYTKCytokinetics Inc | Sell Plan | 3,13463,221 held (−5%) | $85.00 | $266K | -26.0% |
| Jun 29SEC | CYTKCytokinetics Inc | Sell Plan | 38,73063,221 held (−38%) | $82.30 | $3.2M | -23.6% |
| May 5SEC | CYTKCytokinetics Inc | Sell Plan | 23,90663,221 held (−27%) | $76.87 | $1.8M | -18.2% |
| Mar 18SEC | CYTKCytokinetics Inc | Sell | 4,93587,127 held (−5%) | $62.15 | $307K | +1.2% |
- Sell
CFO Sung Lee sold $98K of CYTK at $87.79 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Sung Lee sold $266K of CYTK at $85.00 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Sung Lee sold $3.2M of CYTK at $82.30 — cuts the stake by 38%; pre-scheduled 10b5-1 plan sale.
- Sell
CFO Sung Lee sold $1.8M of CYTK at $76.87 — cuts the stake by 27%; pre-scheduled 10b5-1 plan sale.